Heather Thompson, Senior Editor Dow Chemical as of mid-2016 became 100% owner of Dow Corning’s silicones business. The move created both an opportunity and challenge because it represents a marriage of organic chemistry and inorganic chemistry. How can the two complement each other and drive innovation? And how will the deal affect the medical device […]
Dow (NYSE:DOW) subsidiary Dow Corning presented its latest drug delivery tech for transdermal therapies at the American Assn. of Pharmaceutical Sciences annual meeting. Dow Corning introduced its transdermal delivery patch, the SilAc Hybrid pressure-sensitive adhesive, which combine the properties of acrylic and silicone polymers. The Midland, Mich.-based company also featured its silicone-based topical ingredients with enhanced […]
Long-embattled Dow Corning is still on the hook for complaints about 3 of its implantable tissue expanders after a 6th Circuit Court ruled that the devices count as breast implants for the purposes of a liability settlement worth more than $2 billion.